Statistically significant indeed.
At 24 weeks, statistically significant mean increases of LTBP4 (20.7%), sCXCL16 (29.9%), and sVCAM-1 (18.0%) were observed compared to baseline levels (FDR p-value <0.0005).
CXCL16 (29.9%) has a reported role in "muscle regeneration."
Wonder what this number looks like after 12 months?
Exciting times.
Now interested in how this data affects strategy for new indications.
.
Anp at world muscle society, page-10
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.8¢ |
Change
-0.004(4.35%) |
Mkt cap ! $79.33M | |||
| Open | High | Low | Value | Volume |
| 9.1¢ | 9.2¢ | 8.7¢ | $87.86K | 983.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 61583 | 8.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.8¢ | 16883 | 1 |
View Market Depth
| Last trade - 15.58pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
8.8¢ |
Change
-0.004 ( 2.76 %) |
||||
| Open | High | Low | Volume | ||
| 9.1¢ | 9.1¢ | 8.7¢ | 237651 | ||
| Last updated 15.58pm 17/06/2024 ? | |||||
| PER (ASX) Chart |
